MedTrace Logo

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels

NCT05988866 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272

Last updated 2025-08-22

No results posted yet for this study

Summary

The goal of this clinical trial is to find out if lipodia, a digital health intervention, can help lower cholesterol levels and improve other health measures in adults with high cholesterol.

The main questions it aims to answer are:

* Does lipodia, together with regular treatment, lower LDL cholesterol (bad cholesterol) better than regular treatment alone?
* Does lipodia help improve other health outcomes, like how confident participants feel in managing their health?

Researchers will compare two groups:

* Intervention group: Participants use the lipodia intervention and continue their usual treatment.
* Control group: Participants continue with their usual treatment only.

Participants will:

* Fill out questionnaires online and visit a certified lab at the start of the study, after 3 months, and after 6 months
* Have blood tests at each lab visit to check their cholesterol and other blood fat levels
* Continue with their usual treatment (both groups) and use lipodia, a digital health app, for six months (intervention group only)

Conditions

Interventions

BEHAVIORAL

lipodia

Participants will receive access to the digital health intervention lipodia in addition to TAU.

Sponsors & Collaborators

  • University of Kiel

    collaborator OTHER

  • Gaia AG

    lead INDUSTRY

Principal Investigators

  • Kamila Jauch-Chara, Prof. · Christian-Albrechts-Universität zu Kiel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05988866 on ClinicalTrials.gov